Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

Marijuana extract shown to cut life-threatening seizures in half for children with severe epilepsy. A landmark clinical trial has revealed that a drug derived from medical marijuana can significantly ...

Cora Kuhn is a 5-year-old girl from Verona who loves Disney movies, singing and dancing. She loves to swim in the summer, and play with friends. And since she was just 5 months old, Cora has had 39 se ...

To learn more about our editorial approach, explore The Direct Message methodology. Eight-year-old Freddie Truelove used to have hundreds of seizures a day. Now he has a couple a week — and his mother ...

Dravet syndrome affects about 1 in 17,500 children. Having two daughters with the condition is “extraordinarily uncommon.” ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Zorevunersen led to 75% to 80% seizure reduction in patients with Dravet syndrome, according to ...

The Epilepsy Society has welcomed a new experimental treatment for children with Dravet syndrome which researchers say is safe and can help reduce seizures dramatically.

Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

An experimental new treatment is offering a beacon of hope for children suffering from a rare and severe form of epilepsy, with researchers suggesting it could enable them to "lead much healthier and ...